Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1991-11-27
1999-02-16
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
5303873, 53038875, 4241431, 4241541, C12P 2108, A61K 39395, C08G 7514
Patent
active
058717323
ABSTRACT:
Anti-CD4 antibody homologs, DNA sequences and recombinant DNA molecules encoding them, prophylactic, immunotherapeutic and diagnostic compositions comprising those antibody homologs, and methods for preventing or treating diseases in mammals, including humans, caused by infective agents whose primary targets are CD4.sup.+ lymphocytes. Such diseases include acquired immune deficiency syndrome ("AIDS"), AIDS related complex, and human immunodeficiency virus infection.
REFERENCES:
patent: 4381295 (1983-04-01), Kung et al.
patent: 4515895 (1985-05-01), Kung et al.
patent: 4652447 (1987-03-01), Kung et al.
patent: 4653020 (1987-03-01), Kung et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 4833092 (1989-05-01), Geysen
patent: 4908203 (1990-03-01), Thornton
Linda C. Burkly et al; "Inhibition of HIV Infection by a Novel CD4 Domain 2-Specific Monoclonal Antibody" (The Journal of Immunology--Sep. 1, 1992 pp. 1779-1787).
Wilk et al. Immunology 1990 10-15 (71).
Healy et al. J. Exp. Med. vol. 172 1990 1233-1242.
Trunch et al. Journal of Biological Chemistry. vol. 266(9) 5942, 1991.
Fahey et al. Clin. Exp. Immun. 1992 88, 1-5.
Morrison et al. PNAS. 81. 6851, 1984.
Cohen Science vol. 264 1994. p. 1072.
Jones et al. Nature vol. 321, 1986 p. 522.
Celada et al., 1990, J. Exp. Med. 172:1143-50, "Antibody Raised Against Soluble CD4-rgp 120 Complex Recognizes The CD4 Moiety And Blocks Membrane Fusion Without Inhibiting CD4-gp120 Binding".
Healey et al., 1990, J. Exp. Med. 172:1233-42, "Novel Anti-CD4 Monoclonal Antibodies Separate Human Immunodeficiency Virus Infection And Fusion Of CD4.sup.+ Cells From Virus Binding".
Ibegbu et al., 1989, J. Immunol. 142:2250-56, "Structural Features of CD4 Required For Binding To HIV".
Jameson et al., 1988, Science 240:1335-41, "Location And Chemical Synthesis Of A Binding Site For HIV-1 On The CD4 Protein".
Jones et al., 1986, Nature 321:522-25, "Replacing The Complementarity-Determining Regions In A Human Antibody With Those From A Mouse".
Kieber-Emmons et al., 1989, Biochim. Biophys. Acta 989:281-300, "The gp120-CD4 Interface".
Klatzmann et al., 1984, Nature 312:767-68, "T-Lymphocyte T4 Molecule Behaves As The Receptor For Human Retrovirus LAV".
Kowalski et al., 1987, Science 237:1351-55, "Functional Regions Of The Envelope Clycoprotein Of Human Immunodeficiency Virus Type 1".
Lamarre et al., 1989, EMBO J. 8:3271-77, "Class II MHC Molecules And The HIV gp120 Envelope Protein Interact With Functionally Distinct Regions Of The CD4 Molecule".
Lamarre et al., 1989, Science 245:743-46, "The MHC-Binding And gp120-Binding Functions OF CD4 Are Separable".
Landau et al., 1988, Nature 224:159-62, "The Envelope Glycoprotein Of The Human Immunodeficiency Virus Binds To The Immunoglobulin-Like Domain of CD4".
Lasky et al., 1987, Cell 50:975-85, "Delineation Of A Region Of The Human Immunodeficiency Virus Type 1 gp120 Glycoprotein Critical For Interaction With The CD4 Receptor".
Lasky et al., 1986, Science 233:209-12, "Neutralization Of The AIDS Retrovirus By Antibodies To A Recombinant Envelope Glycoprotein".
Lifson and Engleman, 1989, Immunol. Rev. 109:93-117, "Role Of CD4 In Normal Immunity And HIV Infection".
Lifson et al., 1988, Science 241:712-15, "Synthetic CD4 Peptide Derivatives That Inhibit HIV Infection And Cytopathicity".
Lifson et al., 1986, Science 323:1123-27, AIDS Retrovirus Induced Cytopathology: Giant Cell Formation and Involvement Of CD4 Antigen.
Littmann et al., 1988, Cell 55:541, "Corrected CD4 Sequence".
Lundin et al., 1987, J. Immunol. Methods 97:93-100, "A Specific Assay Measuring Binding Of .sup.125 I-Gp120 From HIV to T4.sup.+ /CD4.sup.+ Cells".
Maddon et al., 1985, Cell, 93-104, "The Isolation And Nucleotide Sequence Of A cDNA Encoding The T Cell Surface Protein T4: A New Member Of The Immunoglobulin Gene Family".
McClure et al., 1987, Nature 330:487-89, "HIV Infection Of Primate Lymphocytes And Conservation Of The CD4 Receptor".
McDougal et al., 1986, Science 231:382-85, "Binding Of HTLV-III/LAV To T4.sup.+ T Cells By A Complex Of The 110 Viral Protein And The T4 Molecule".
McDougal et al., 1986, J. Immunol. 137:2937-44, "Binding Of The Human Retrovirus HTLV-III/LAV/ARV/HIV To The CD4 (T4) Molecule: Conformation Dependence, Epitope Mapping, Antibody Inhibition, And Potential For Idiotypic Mimicry".
Arthos, et al., 1989, Cell 57:469-81, "Identification Of The Residues In Human CD4 Critical For The Binding Of HIV".
Bach et al., 1981, J. Immunol. 127:980-82, "Unusual Phenotypes Of Human Inducer T Cells As Measured By OKT4 And Related Monoclonal Antibodies".
Bates et al., 1989, Prot. Engng. 3:13-21, "A Predicted Three-Dimensional Structure For The Human Immunodeficiency Virus Binding Domains Of CD4 Antigen".
Berger et al., 1988, Prod. Natl. Acad. Sci. USA, 85:2357-61, "A Soluble Recombinant Polypeptide Comprising The Amino-Terminal Half Of The Extracellular Region Of The CD4 Molecule Contains An Active Binding Site For Human Immunodeficiency".
Biddison et al., 1982, J. Exp. Med. 156:1065-76, "Possible Involvement Of The OKT4 Molecule In T Cell Recognition Of Class II HLA Antigens."
Camerini and Seed, 1990, Cell 60:747-54, "A CD4 Domain Important For HIV-Mediated Syncytium Formation Lies Outside The Virus Binding Site."
Chao et al., 1989, J. Biol. Chem. 264:5812-17, "A 113-Amino Acid Fragment Of CD4 Produced In Escherichia coli Blocks Human Immunodeficiency Virus-Induced Cell Fusion."
Clayton et al., 1989, Nature 339:548-51, "Identification Of Human CD4 Residues Affecting Class II MHC Versus HIV-1 gp120 Binding."
Clayton et al., 1988, Nature 335:363-66, "Substitution Of Murine For Human CD4 Residues Identifies Amino Acids Critical For HIV-gp120 Binding."
Dalgleish et al., Nov. 1987, Lancet 2:1047-50, "Neutralisation Of HIV Isolates By Anti-Idiothypic Antibodies Which Mimic The T4 (CD4) Epitope: A Potential AIDS Vaccine".
Dalgleish et al., 1984, Nature 312:763-67, "The CD4 (T4) Antigen Is An Essential Component Of The Receptor For The AIDS Retrovirus".
Devlin et al., 1990, Science 249:404-07, "Random Peptide Libraries: A Source Of Specific Protein Binding Molecules".
Engleman et al., 1981, J. Immunol. 127:2124-29, "Activation Of Human T Lymphocyte Subsets: Helper And Suppressor/Cytotoxic T Cells Recognize And Respond To Distinct Histocompatibility Antigens".
Fisher et al., 1988, Nature 331: 76-78, "HIV Infection Is Blocked In Vitro By Recombinant Soluble CD4".
Garlick et al., 1990, AIDS Res. Hum. Retroviruses 6:465-79, "Escherichia coli Expression, Purification, And Biological Activity Of A Truncated Soluble CD4".
Gay et al., 1987, Nature 328:626-29, "Functional Interaction Between Human T-Cell Protein CD4 And The Major Histocompatibility Complex HLA-DR Antigen".
Gefter et al., 1977, Somat. Cell Gent. 3:231-36, "A Simple Method For Polyethylene Glycol-Promoted Hybridization Of Mouse Myeloma Cells".
Habeshaw and Dalgleish, 1989, J. AIDS 2:457-698, "The Relevance Of HIV env/CD4 Interactions To The Pathogenesis Of Acquired Immune Deficiency Syndrome".
Hillman et al., 1990, J. Immunol. 144:2131-39, Chemically Induced CD4 Mutants Of A Human T Cell Line-Evidence for Dissociation between Binding of HIV I Envelope and Susceptibility to HIV I Infection and Synctia Formation.
Merkenschlager et al., 1990, J. Immunol. 145:2839-45, "Functional Epitope Analysis Of the Human CD4 Molecule--The MHC Class II-Dependent Activation of Resting T Cells Is Inhibited by Monoclonal Antibodies to CD4 Regardless whether or Not They Recognize Epitopes Involved in the Binding of MHC Class II or HIV gp120".
Mizukami et al., 1988, Proc. Natl. Acad. Sci. USA 85:9273-77, "Binding Region For Human Immunodeficiency Virus (HIV) And Epitopes For HIV-Blocking Mononclonal Antibodies Of The CD4 Molecule Defined By Site-Directed Mutagenesis".
Morrison, et al., 1984, Proc. Natl. Acad. Sci. USA, 81:6851-55, "Chimeric Human Antibody Molecules: Mouse Antigen-Binding Domains With Human Constant Region Domains".
Negoro and Tanigaki, 1986, Human Immunol. 15:137-49, "Serological And Functional Analysis Of The Epitope Clusters On Leu3/T4 Antigen".
Perno et al., 1990, J. Exp. Med. 171:1043-56,
Burkly Linda C.
Chisholm Patricia L.
Rosa Joseph J.
Rosa Margaret D.
Thomas David W.
Bansal Geetha
Biogen Inc.
Feisee Lila
Kaplan Warren A.
LandOfFree
Anti-CD4 antibody homologs useful in prophylaxis and treatment o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-CD4 antibody homologs useful in prophylaxis and treatment o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-CD4 antibody homologs useful in prophylaxis and treatment o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2059657